InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 171

Thursday, 09/06/2012 9:52:01 AM

Thursday, September 06, 2012 9:52:01 AM

Post# of 267
2:09AM Jazz Pharma sells its Women's Health Business to Meda for $95 mln in cash (JAZZ) 20.66 : Co announces a definitive agreement to sell its women's health business, which includes six products, to Meda for $95 mln in cash. The products included in the sale are Elestrin, Gastrocrom, Natelle One, AVC Cream, Gesticare DHA and Urelle. Net sales for these products in 2011 totaled $30.4 mln. As part of the transaction, Meda will offer positions to ~60 employees who directly support these products.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAZZ News